Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 13, 298-307, March 1, 1953]
© 1953 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Furth, J.
Right arrow Articles by Gadsden, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Furth, J.
Right arrow Articles by Gadsden, E. L.

Quantitative Relationship between Thyroid Function and Growth of Pituitary Tumors Secreting TSH*

J. Furth, W. T. Burnett, Jr. and E. L. Gadsden

( Biology Division, Oak Ridge National Laboratory, Oak Ridge, Tenn.)

The relationship of growth of TSH-secreting pituitary tumors to thyroid function was studied by destroying or depressing the thyroid gland of mice with graded doses of I131, grafting tumors on such animals, and correlating tumor growth with thyroid function. The results indicate that proliferation of grafted TSH-secreting pituitary tumor cells depends on the secretion of TH.

Near complete or complete destruction of the thyroid follows administration of a single dose of 200 or more µc. of I131. This provides the maximum stimulus to pituitary growth. A lower dose, about 75 µc., produces a lasting depression of the thyroid, some follicles of which, although normal in appearance, are incapable of undergoing fully compensating hyperplasia. In most mice 25 µc. interferes little, if at all, with the thyroid function, with ability of this gland to be stimulated by TSH, and with its capacity to inhibit the growth of pituitary tumors. The inverse relationship between thyroid function, as indicated by its ability to take up I131, and stimulation of the pituitary tumor grafts is almost quantitative.

Cells of thyroid glands which escaped destruction by large doses of I131 do not have the ability to undergo a fully compensating hyperplasia. This may be due in part to the stenosing "radiation arteritis" and diffuse fibrosis in the thyroid region caused by I131.

Radiothyroidectomy causes an increased total-body retention (or diminished elimination) of I131 during the first 24 hours following injection. Pituitary tumor grafts secreting TSH further enhance total-body retention of I131. The sites of this I131 are not precisely known. In radiothyroidectomized mice (with and without tumor) the elimination of the retained I131 is rapid. In normal mice bearing grafted tumors most of the retained radioiodine is in the thyroid, and its retention is lasting.

* Work performed under Contract No. W-7405-eng-26 for the Atomic Energy Commission.

Received 11/26/52.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1953 by the American Association for Cancer Research.